calendar
364 catalysts · 4,207 phase readout · 2,217 8k filing · 282 earnings · 172 phase 2 completion · 110 drug shortage · 73 phase 1 completion
next 91 dayslessmore
MonWedFri
364 catalysts · 4,207 phase readout · 2,217 8k filing · 282 earnings · 172 phase 2 completion · 110 drug shortage · 73 phase 1 completion
NS grant. $633,378. PI: Alba Miranda Azola
AI grant. $88,250. PI: Jennifer Lynn Hyde
AI grant. $440,211. PI: Julie Dunning Hotopp
ES grant. $605,091. PI: Yike Shen
NS grant. $429,000. PI: NAGI G AYAD
AI grant. $161,244. PI: TERESA GIL GIL
CA grant. $415,623. PI: STEPHEN J KADLECEK
AI grant. $267,000. PI: Qianxia Zhang
DK grant. $769,882. PI: Cary Ragan Boyd-Shiwarski
NR grant. $3,480,544. PI: Michelle Trivedi
ES grant. $795,869. PI: Sean M Harris
AI grant. $660,723. PI: Hongyan Guo
AI grant. $843,182. PI: Christopher F Basler
AT grant. $788,967. PI: ADAM L. Halberstadt
AI grant. $209,758. PI: Paul K Drain
AT grant. $601,259. PI: Ashley E. Mason
NS grant. $568,920. PI: Theresa Currier Thomas
CA grant. $496,357. PI: DANIEL J BRAT
AT grant. $170,640. PI: Julia E. Hooker
AI grant. $210,302. PI: William Evan Johnson
DK grant. $231,000. PI: Roger D. Cone
NS grant. $230,562. PI: Thuy Nguyen
ES grant. $117,747. PI: Rebecca Sugrue
Anticipated earnings call for ACME UNITED CORP ($ACU).
Therapy area: Infectious Disease. Indication: Pulmonary Tuberculosis
Anticipated earnings call for Sanofi ($SNY).
Therapy area: Infectious Disease, Respiratory. Indication: Asthma, Influenzavirus A Infections, Influenzavirus B Infections
Therapy area: Gastrointestinal, Infectious Disease, Oncology. Indication: Acral Lentiginous Melanoma, Adenocarcinoma Of The Gastroesophageal Junction, Adenoid Cystic Carcinoma (ACC), Adrenocortical Carcinoma (Adrenal Cortex Cancer), Anaplastic Thyroid Cancer, Bile Duct Cancer (Cholangiocarcinoma), Bladder Cancer, Breast Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma (cSCC), Endometrial Cancer, Ependymoma, Epithelial Ovarian Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Ewing S
Therapy area: Oncology, Undisclosed. Indication: Lung Cancer, Solid Tumor, Unspecified Rare Disease
Therapy area: Dermatology. Indication: Diabetic Foot Ulcers
Therapy area: Dermatology. Indication: Chronic Urticaria
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Anticipated earnings call for NOVARTIS AG ($NVS).
Anticipated earnings call for INCYTE CORP ($INCY).
Anticipated earnings call for ECOLAB INC. ($ECL).
Anticipated earnings call for Orion Group Holdings Inc ($ORN).
Therapy area: Metabolic Disorders. Indication: Type 1 Diabetes (Juvenile Diabetes)
Anticipated earnings call for AbbVie Inc. ($ABBV).
Anticipated earnings call for ASTRAZENECA PLC ($AZN).
Anticipated earnings call for GSK plc ($GSK).
Anticipated earnings call for REGENERON PHARMACEUTICALS, INC. ($REGN).
Anticipated earnings call for TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA).
Anticipated earnings call for GLAUKOS Corp ($GKOS).
Anticipated earnings call for BIOGEN INC. ($BIIB).
Anticipated earnings call for Bausch & Lomb Corp ($BLCO).